Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Acute and Chronic Wounds
4.2.2 Rising Number of Burn Injuries, Trauma and Accidents
4.2.3 Increase In Number of Surgeries
4.3 Market Restraints
4.3.1 High Cost of the Products and Lack of Reimbursements
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Biomaterials
5.1.2 Skin Substitutes
5.1.2.1 Biological Skin-substitute
5.1.2.2 Synthetic Skin-substitutes
5.1.3 Growth Factors
5.2 By End User
5.2.1 Hospitals
5.2.2 Clinics
5.2.3 Home Healthcare
5.3 By Application
5.3.1 Chronic Wounds
5.3.2 Acute Wounds
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Smith and Nephew plc
6.1.2 MIMEDX
6.1.3 Tissue Regenix
6.1.4 Organogenesis Inc.
6.1.5 ACell Inc.
6.1.6 Integra LifeSciences
6.1.7 Bioventus LLC.
6.1.8 Human BioSciences
6.1.9 Fibroheal
6.1.10 Wright Medical Group N.V.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS